BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36462523)

  • 1. Vaccines need equity to really work.
    The Lancet Microbe
    Lancet Microbe; 2022 Dec; 3(12):e888. PubMed ID: 36462523
    [No Abstract]   [Full Text] [Related]  

  • 2. Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review.
    Patikorn C; Cho JY; Lambach P; Hutubessy R; Chaiyakunapruk N
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
    Taha MK; Martinon-Torres F; Köllges R; Bonanni P; Safadi MAP; Booy R; Smith V; Garcia S; Bekkat-Berkani R; Abitbol V
    Expert Rev Vaccines; 2022 May; 21(5):659-674. PubMed ID: 35271781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing efforts beyond tailored promotional campaigns by understanding contextual factors shaping vaccine hesitancy among equity-deserving populations in Canada: an exploratory qualitative study.
    Nascimento LG; Dubé È; Burns KE; Brown P; Calnan M; Ward PR; Filice E; Herati H; Ike NAU; Rotolo B; Meyer SB
    Int J Equity Health; 2023 Oct; 22(1):209. PubMed ID: 37805472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equity in disease prevention: Vaccines for the older adults - a national workshop, Australia 2014.
    Raina MacIntyre C; Menzies R; Kpozehouen E; Chapman M; Travaglia J; Woodward M; Jackson Pulver L; Poulos CJ; Gronow D; Adair T
    Vaccine; 2016 Nov; 34(46):5463-5469. PubMed ID: 27686835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.
    Chang AY; Riumallo-Herl C; Perales NA; Clark S; Clark A; Constenla D; Garske T; Jackson ML; Jean K; Jit M; Jones EO; Li X; Suraratdecha C; Bullock O; Johnson H; Brenzel L; Verguet S
    Health Aff (Millwood); 2018 Feb; 37(2):316-324. PubMed ID: 29401021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mobile vaccine equity enhancement program-a model program for enhancing equity in vaccine availability based at a large health care system.
    Broach J; Brown O; McEachern C; Forget J; Lancette P; Soucie N; Inzerillo J; Klugman R; Tosi S; Haddad A; Manor P; Bylund R; Dellostritto G; Grecchi M; Camelo C; Shirshac J; Eshghi K; Vega N; Hampson S; Follwell K; Gonzalez R; Hicks T; McCandless V; VanStratten T; Botros M; Jalbert T; Merwin C; Schellhammer W; Pelto I; Rodriguez M; LaPriore C; Lowell M; Radigan E; Gull L; Gruszecki A; Benoit S; Dickson E; Muller M
    Front Public Health; 2023; 11():1271162. PubMed ID: 37915810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 vaccines and investment performance: Evidence from equity funds in European Union.
    Mirza N; Umar M; Mangafic J
    Financ Res Lett; 2023 May; 53():103650. PubMed ID: 36686060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A public health framework for the equitable global allocation of vaccines: COVID-NEEDS.
    Jain V; Lorgelly P
    J Public Health Policy; 2022 Mar; 43(1):155-167. PubMed ID: 35022543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage and Equity of Childhood Vaccines in China.
    Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
    JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A standardized approach for measuring multivariate equity in vaccination coverage, cost-of-illness, and health outcomes: Evidence from the Vaccine Economics Research for Sustainability & Equity (VERSE) project.
    Patenaude B; Odihi D; Sriudomporn S; Mak J; Watts E; de Broucker G
    Soc Sci Med; 2022 Jun; 302():114979. PubMed ID: 35462106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines--a wonderful tool for equity in health.
    Jimenez J
    Vaccine; 2001 Mar; 19(17-19):2201-5. PubMed ID: 11257333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public support in the United States for global equity in vaccine pricing.
    Chan Y; Datt G; Islam A; Rai B; Wang LC
    Sci Rep; 2022 May; 12(1):8960. PubMed ID: 35624169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Equity in the Transnational Allocation of Vaccines Against Emerging Pathogens: A Multi-Modal Approach.
    Rutschman AS
    J Law Med Ethics; 2023; 51(2):247-257. PubMed ID: 37655573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate Assessment of Vaccine Equity in Cambodia: A Longitudinal VERSE Tool Case Study Using Demographic and Health Survey 2004, 2010, and 2014.
    Zhao Y; Mak J; de Broucker G; Patenaude B
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine equity: Past, present, and future.
    van der Graaf R; Browne JL; Baidjoe AY
    Cell Rep Med; 2022 Mar; 3(3):100551. PubMed ID: 35474741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Royal Australasian College of Surgeons Rural Health Equity Strategic Action Plan: excellence through equity.
    Clancy B
    ANZ J Surg; 2022 Sep; 92(9):1990-1994. PubMed ID: 35929365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine equity in COVID-19: a meta-narrative review.
    Borowicz J; Zhang Z; Day G; Pinto da Costa M
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36524409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human rights in health equity: cervical cancer and HPV vaccines.
    Erdman JN
    Am J Law Med; 2009; 35(2-3):365-87. PubMed ID: 19697754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring equity with pre-clinical planning for chlamydia vaccines.
    Collar AL; Clarke TN; Jamus AN; Frietze KM
    NPJ Vaccines; 2023 Sep; 8(1):131. PubMed ID: 37673890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.